Ngā hua rapu - Chen, Hung‐Jen
- E whakaatu ana i te 1 - 20 hua o te 25
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy mā Cheng, Wen-Chien, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Hung-Jen
I whakaputaina 2021Text -
6
-
7
What if a tumor is significantly enlarged just before stereotactic body radiation therapy? A case report and review of the literature mā Chen, Hung‐Jen, Liang, Ji‐An, Chen, Chih‐Yi, Yu, Yang‐Hao, Chien, Chun‐Ru
I whakaputaina 2016Text -
8
Etiologies of delayed diagnosis and six‐month outcome of patients with newly diagnosed advanced lung cancer with respiratory failure at initial presentation mā Tseng, How‐Yang, Shen, Yi‐Cheng, Lin, Yen‐Sung, Tu, Chih‐Yen, Chen, Hung‐Jen
I whakaputaina 2020Text -
9
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma mā Chen, Hung-Jen, Tu, Chih-Yen, Huang, Kuo-Yang, Chien, Chun-Ru, Hsia, Te-Chun
I whakaputaina 2020Text -
10
-
11
Comparison of recurrence risk between patients with clinically node‐positive and ‐negative stage I non‐small cell lung cancer following surgery: A propensity score matching analysi... mā Huang, Kuo‐Yang, Chen, Hung‐Jen, Lin, Ching‐Hsiung, Wang, Bing‐Yen, Cheng, Ching‐Yuan, Lin, Sheng‐Hao
I whakaputaina 2022Text -
12
-
13
Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center, Prospective, Double-Blin... mā Li, Chia-Ling, Hsia, Te-Chun, Yang, Su-Tso, Chao, Kun-San Clifford, Tu, Chih-Yen, Chen, Hung-Jen, Li, Chia-Hsiang
I whakaputaina 2022Text -
14
The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department mā Chen, Wei-Cheng, Huang, Kuo-Yang, Yao, Chih-Wei, Wu, Cing-Feng, Liang, Shinn-Jye, Li, Chia-Hsiang, Tu, Chih-Yeh, Chen, Hung-Jen
I whakaputaina 2016Text -
15
The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan mā Cheng, Wen‐Chien, Shen, Yi‐Cheng, Chien, Chun‐Ru, Liao, Wei‐Chih, Chen, Chia‐Hung, Hsia, Te‐Chun, Tu, Chih‐Yeh, Chen, Hung‐Jen
I whakaputaina 2022Text -
16
When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan mā Chen, Chieh-Lung, Wang, Sing-Ting, Liao, Wei-Chih, Chen, Chia-Hung, Tu, Chih-Yen, Chen, Hung-Jen, Hsia, Te-Chun, Cheng, Wen-Chien
I whakaputaina 2022Text -
17
Meta-Analysis of in vitro-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages in vivo mā Chen, Hung-Jen, Li Yim, Andrew Y. F., Griffith, Guillermo R., de Jonge, Wouter J., Mannens, Marcel M. A. M., Ferrero, Enrico, Henneman, Peter, de Winther, Menno P. J.
I whakaputaina 2019Text -
18
Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses mā Willemsen, Lisa, Chen, Hung-Jen, van Roomen, Cindy P. A. A., Griffith, Guillermo R., Siebeler, Ricky, Neele, Annette E., Kroon, Jeffrey, Hoeksema, Marten A., de Winther, Menno P. J.
I whakaputaina 2022Text -
19
The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients mā Li, Chia-Hsiang, Chen, Hung-Jen, Chen, Wei-Chun, Tu, Chih-Yen, Hsia, Te-Chun, Hsu, Wu-Huei, Chang, Chiz-Tzung, Huang, Chiu-Ching, Bau, Da-Tian, Chou, Che-Yi
I whakaputaina 2021Text -
20
Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study mā Shen, Te-Chun, Chung, Wei-Sheng, Lin, Cheng-Li, Wei, Chang-Ching, Chen, Chia-Hung, Chen, Hung-Jen, Tu, Chih-Yen, Hsia, Te-Chun, Shih, Chuen-Ming, Hsu, Wu-Huei, Chung, Chi-Jung
I whakaputaina 2014Text